Tweet
Business Recorder
<img alt="" height="1" width="1" />
Edwards Lifesciences' New Heart Valve Meets Trial's Goal
NASDAQ
Edwards Lifesciences ( EW ) said a new version of its nonsurgical heart valve met its primary study goal in a late-stage trial, and that it would seek U.S. regulatory approval later this year. If the device is approved, it could help Edwards extend its lead in the ...
Edwards' Sapien XT Equal to Older Device to Repair Aortic ValveBloomberg
PARTNER II: Lower-profile Sapien XT valve performs similar to original valveHealio
Redesigned Edwards heart valve shows improvement in studyWTAQ
all 6 news articles »
More...